Response to Omoleye, Esserman, Olufunmilayo

Affiliations

¹ Departments of Medicine and Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
² VA Division of General Internal Medicine, University of California San Francisco, San Francisco, CA, USA.
³ Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.
⁴ Departments of Surgery and Radiology, University of Vermont, Burlington, VT, USA.
⁵ The Dartmouth Institute for Health Policy and Clinical Practice and Dartmouth Cancer Center, Dartmouth Geisel School of Medicine, Lebanon, NH, USA.
⁶ Department of Public Health Sciences, University of California, Davis, Davis, CA, USA.

Karla Kerlikowske et al. J Natl Cancer Inst. 2024.

. 2024 Apr 5;116(4):629-630.

doi: 10.1093/jnci/djae011.

¹ Departments of Medicine and Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
² VA Division of General Internal Medicine, University of California San Francisco, San Francisco, CA, USA.
³ Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.
⁴ Departments of Surgery and Radiology, University of Vermont, Burlington, VT, USA.
⁵ The Dartmouth Institute for Health Policy and Clinical Practice and Dartmouth Cancer Center, Dartmouth Geisel School of Medicine, Lebanon, NH, USA.
⁶ Department of Public Health Sciences, University of California, Davis, Davis, CA, USA.

No abstract available

Conflict of interest statement

The authors report no potential conflicts of interest.

1. Kerlikowske K, Zhu W, Su YR, et al.Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density. J Natl Cancer Inst. 2024;116(2):249-257. - PMC - PubMed
1. Omoleye OJ, Esserman LJ, Olopade OI.. RE: Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density. J Natl Cancer Inst. 2024;116(4):627-628. - PubMed
1. Warner E, Hill K, Causer P, et al.Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol. 2011;29(13):1664-1669. - PMC - PubMed
1. Saadatmand S, Geuzinge HA, Rutgers EJT, et al.; FaMRIsc Study Group. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Lancet Oncol. 2019;20(8):1136-1147. - PubMed
1. Kerlikowske K, Bissell M, Sprague BL, et al.Advanced breast cancer definitions by staging system examined in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst. 2021;113(7):909-916. - PMC - PubMed